PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Taskinen, Marja-Riitta
ED  - Kastelein, John
TI  - Beyond Statins in Treatment of Dyslipidemia
DP  - 2015 Nov 27
TA  - MD Conference Express
PG  - 15--16
VI  - 15
IP  - 28 suppl 1
4099  - http://mdc.sagepub.com/content/15/28_suppl_1/15.short
4100  - http://mdc.sagepub.com/content/15/28_suppl_1/15.full
AB  - A reservoir of risk in the treatment of dyslipidemia calls for optimization of statin treatment, which involves monitoring of response and compliance and adjustment of dose as needed. Also, other therapeutic approaches are needed. Niacin and fibrates are questionable options. Ezetimibe, PCSK9 inhibitors, mipomersen, and lomitapide have potential merit.